Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells

Metformin (MET) is increasingly implicated in reducing the incidence of multiple cancer types in patients with diabetes. However, similar effects of MET in non-diabetic women with endometrial cancer (EC) remain unknown. In a pilot study, obese non-diabetic women diagnosed with type 1, grade 1/2 EC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabona, John Mark P, Burnett, Alexander F, Brown, Dustin M, Quick, Charles M, Simmen, Frank A, Montales, Maria Theresa E, Liu, Shi J, Rose, Tyler, Alhallak, Iad, Siegel, Eric R, Simmen, Rosalia CM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077930/
https://www.ncbi.nlm.nih.gov/pubmed/32046384
http://dx.doi.org/10.1007/s43032-019-00019-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077930/
https://www.ncbi.nlm.nih.gov/pubmed/32046384
http://dx.doi.org/10.1007/s43032-019-00019-2

Ejemplares similares